2021-09-30-accounts - Cancer And Polio Research Fund Limited

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

			Page
Reference and administrative		details ofthe charity, its trustees and advisers
Trustees' Report			4-10
Independent Auditor's	Report		11-14
Statement ofFinancial	Activities		15
Balance Sheet			16
Cash Flow Statement			17
Notes to the Fin an cia I	Statements		18-28

		Unrestricted
		and total	Total		Total
		funds	Funds		funds
		Year ended 30'"	Year ended 30~	year ended	30'"
		September	September	September
		2021	2021	2020
	Note
INCOME FROM:
Donations and legacies		54,460	54,460		2,767
Investment income		1,037	1,037		1,255
TOTAL INCOME		55,497	55,497		4,022
EXPENDITURE ON:
Raising funds:
Donation and legacy generation costs		4,298	4,298		650
Charitable activities		111,621	111,621		9,955
TOTAL EXPENDITURE		115,919	115,919		10,605
NET EXPENDITURE BEFORE INVESTMENT GAINS		(60,922)	(60,922)		(6,583)
Gains/(losses) on investments		32,926	32,926		(8,974)
NET EXPENDITURE BEFORE TRANSFERS		(27,496)	(27,496)	(15,557)
Transfers between funds
NET IVIOVEMENT IN FUNDS		(27,496)	(27,496)	(15,557)
RECONCILIATION OF FUNDS:
Total funds brought forward		181,348	181,348	196,905
TOTAL FUNDS CARRIED FORWARD		153,852	153,852	181,348

				Note	2021	2020
					E	E
Cash flows from operating		activities:
Net cash used	in operating	activities			(6,250)	47,517
Cash flows from investing		activities:
Dividends and	interest from investments				1,037	1,256
Purchase of investments					(1,037)	(1,256)
Net cash provided by investing activities
Change in cash	and cash equivalents		in the year		(6,250)	47,517
Cash and cash	equivalents	brought forward			59,930	12,413
Cash and cash	equivalents	carried forward		12	53,680	59,930

		Yearended	Year ended
		30September	30September
		2021	2020
		f
Direct	mail expenses and costs of InTouch Magazine	3,580
Other	fundra ising costs	718	650
		4,298	650

b) Governance	b) Governance	costs
									Year ended	Year ended
									30September	30September
									2021 f	2020f
Governance	legal	and professional	fees
Governance	share	ofsupport costs								1,355
Governance	expense —Accountancy			fees					1,660	3,600
Governance Research	— Management fee			from	North		West	Cancer	5,000	5,000
									6,660	9,955
During the year, no		Trustees received		any	remuneration			(2020;f0).
During the year, no		Trustees received		any	benefits	in kind (2020:f0).
During the year, no		Trustees received		reimbursement			of	travel and accommodation expenses (2020:0).

		Listed
		securities
		(Market value)
		f
At 1October 2020		134,968
Movement in cash for	the year	1,037
Realised and unrealised investments	gains on	32,926
At 30September 2021		168,931

				2021 f	2020f
Prepayments	and	accrued	income	43,196
				43,196

				2021 f	2020f
Amounts	owed to NWCR,		the parent company	41,941	11,750
Accruals	and deferred	income		1,600	1,800
				43,541	13,550
b. CREDITORS: Amounts			falling due after more than one year
				2021 f	2020f
Amounts	owed to NWCR,		the parent company	68,414
Accruals	and deferred	income
				68,414

			2021	2020
			E	E
Accrued	as at 1October 2020
Grants	made during the year to the University	of Liverpool	104,961
Grants	paid and other movements
Accrued	30September 2021		104,961
Payable	as follows:
Grants	payable (1yr- institutional		36,547
Grants	payable &1yr —institutional		68,414
Total grants payable			104,961

	Balance at				Balance at
	1			Gains /	30
	October				September
	2020	Income	Expenditure	(Losses)	2021
	f	f	E	E	E
Unrestricted	and
total funds
General funds	181,348	55,497	(115,919)	32,926	153,852
Total offunds	181,348	55,497	(115,919)	32,926	153,852
STATEMENT OF FUNDS —PRIOR YEAR
	Balance at				Balance at
	6Sept.			Gains/	30Sept.
	2019 f	income	Expenditure E	(Losses) E	2020f
Unrestricted	and
total funds
Other General funds	196,905	4,022	(10,605)	(8,974)	181,348
Total offunds	196,905	4,022	(10,605)	(8,974)	181,348

NALYSIS OF NET AS	SETS BETWEEN FUNDS —CURRENT YEAR
		Unrestricted
		and total	Total
		funds	funds
		30th	30th
		September	September
		2021	2021
		f	f
Fixed asset investments		168,930	168,930
Current assets		96,876	96,876
Creditors due within	one year	(43,541)	(43,541)
Creditors due after	one year	(68,414)	(68,414)
		153,852	153,852
NALYSIS OF NET ASSETS BETWEEN FUNDS —PRIOR YEAR
		Unrestricted
		and total	Total
		funds	funds
		30th	30th
		September	September
		2020f	2020f
Fixed asset investments		134,968	134,968
Current assets		59,930	59,930
Creditors due within	one year	(13,550)	(13,550)
Creditors due after	one year
		181,348	181,348

				2021	2020
				E	f
Net expenditure for	the year (as per Statement of Financial Activities)			(27,496)	(15,557)
Adjustment for:
Gains on investments				(32,926)	8,974
Dividends, interest and returns			on investments	(1,037)	(1,256)
(Increase) / Decrease	in debtors			(43,196)	53,191
Increase in creditors				98,405	2,165
Net cash used in operating		activities		(6,250)	47,517